| Literature DB >> 27630634 |
Shaohui Wang1, Xin Liu2, Xuan Xu1, Denghui Yang1, Dong Wang1, Xiangan Han1, Yonghong Shi1, Mingxing Tian1, Chan Ding1, Daxin Peng3, Shengqing Yu1.
Abstract
Type III secretion systems (T3SSs) are crucial for bacterial infections because they deliver effector proteins into host cells. The Escherichia coli type III secretion system 2 (ETT2) is present in the majority of E. coli strains, and although it is degenerate, ETT2 regulates bacterial virulence. An ATPase is essential for T3SS secretion, but the function of the ETT2 ATPase has not been demonstrated. Here, we show that EivC is homologous to the β subunit of F0F1 ATPases and it possesses ATPase activity. To investigate the effects of ETT2 ATPase EivC on the phenotype and virulence of avian pathogenic Escherichia coli (APEC), eivC mutant and complemented strains were constructed and characterized. Inactivation of eivC led to impaired flagella production and augmented fimbriae on the bacterial surface, and, consequently, reduced bacterial motility. In addition, the eivC mutant strain exhibited attenuated virulence in ducks, diminished serum resistance, reduced survival in macrophage cells and in ducks, upregulated fimbrial gene expression, and downregulated flagellar and virulence gene expression. The expression of the inflammatory cytokines interleukin (IL)-1β and IL-8 were increased in HD-11 macrophages infected with the eivC mutant strain, compared with the wild-type strain. These virulence-related phenotypes were restored by genetic complementation. These findings demonstrate that ETT2 ATPase EivC is involved in the motility and pathogenicity of APEC.Entities:
Keywords: ATPase; EivC; avian pathogenic E. coli; motility; virulence
Year: 2016 PMID: 27630634 PMCID: PMC5005338 DOI: 10.3389/fmicb.2016.01387
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Bacterial strains and plasmids used in this study.
| Strains or plasmids | Characteristics | Reference |
|---|---|---|
| APCE94 | APEC wild-type strain, O78 serotype | This study |
| APCE94ΔeivC | This study | |
| APCE94CΔeivC | APCE94ΔeivC with plasmid pSTV28-eivC | This study |
| DH5α | F-, | TIANGEN |
| BL21 (DE3) | F-, | TIANGEN |
| pET28a(+) | Kan, F1 origin, His tag | Novagen |
| pET28a-eivC | pET28a (+) carrying | This study |
| pSTV28 | Cm, lacZ | Takara |
| pSTV28-eivC | pSTV28 derivative harboring | This study |
| pKD46 | Amp; expresses λ red recombinase | |
| pKD3 | Cm gene, template plasmid | |
| pCP20 | Cm, Amp, yeast Flp recombinase gene, FLP |
Primers used in this study.
| Primers | Sequence (5′ to 3′)a | Target genes | Products size |
|---|---|---|---|
| eivCEx-F | CGC | 1317 bp | |
| eivCEx-R | CCC | ||
| eivCMu-UF | AGAAGTTAACCCTACTGGACCC | Upstream region of | 767 bp |
| eivCMu-UR | GAAGCAGCTCCAGCCTACACTTGCCAGCTTGCATAAATTT | ||
| eivCMu-CF | AAATTTATGCAAGCTGGCAAGTGTAGGCTGGAGCTGCTTC | pKD3 | 1014 bp |
| eivCMu-CR | CTGATAAGTCGATTAACTT CATATGAATATCCTCCTTAG | pKD3 | |
| eivCMu-DF | CTAAGGAGGATATTCATATGAAGTTAATCGACTTATCAG | 671 bp | |
| eivCMu-DR | GGATTCCTGTCAACCTAGAGAG | Downstream region of | |
| C1 | TTATACGCAAGGCGACAAGG | pKD3 | |
| C2 | GATCTTCCGTCACAGGTAGG | pKD3 | |
| eivCup-F | GGCTGATAGCAATTCGCC | Upstream region of | 3003 bp |
| eivCdown-R | CTGCGGTCCATTTATTTTGT | Downstream region of | |
| eivCCo-F | GCG | Upstream region of | 2031 bp |
| eivCCo-R | CGC | Downstream region of | |
| dnaE RT-F | ATGTCGGAGGCGTAAGGCT | 181 bp | |
| dnaE RT-R | TCCAGGGCGTCAGTAAACAA | ||
| motA RT-F | GCTTTCTAATCTGAACGGTTACGC | 96 bp | |
| motA RT-R | TCCAGCTCAATAAACGACGGAC | ||
| flgB RT-F | GCAGCAAACATCGCCAATGCC | 101 bp | |
| flgB RT-R | GTTGCATCCCGTCCACGTT | ||
| flgD RT-F | GCACAAATCAGCACGGTCAGCG | 122 bp | |
| flgD RT-R | ATCATCACGCCGTGACCGATCA | ||
| flgF RT-F | ACGTCGCGTTGCAGCAGGAT | 128 bp | |
| flgF RT-R | TATCACCGGATGCCCCTGAA | ||
| fliC RT-F | CCAGTAGCTCCGTTAATCCCT | 132 bp | |
| fliC RT-R | AGTTTTGCTCAGTACACCGGAA | ||
| fimC RT-F | GCCGATGGTGTAAAGGATGG | 127 bp | |
| fimC RT-R | AACTTTCCCGATCCTGTGGC | ||
| ompA RT-F | GCTGAGCCTGGGTGTTTCCT | 171 bp | |
| ompA RT-R | TCCAGAGCAGCCTGACCTTC | ||
| aatA RT-F | CCGTACCCGTGTCGCTGTTAC | 98 bp | |
| aatA RT-R | CAGCATTATCAGCATTGCCACT | ||
| iss RT-F | CCGACAGCAGTAACACCAAAGG | 105 bp | |
| iss RT-R | TTCTGCACCGCCAACAAATT | ||
| tsh RT-F | GCACGAACTGGGAAGTATGGA | 118 bp | |
| tsh RT-R | GGCATAGAAACCACCACCCC | ||
| fyuA RT-F | TTGGCGACCAGGGTAAGAGC | 145 bp | |
| fyuA RT-R | AGACCCGCAGTAGGCACGAT | ||
| iucD RT-F | GCTGGGTAGCAGACGGATAT | 95 bp | |
| iucD RT-R | GCATCACTGCCGATTCTTTA | ||
| chβactin-F | GAGAAATTGTGCGTGACATCA | 152 bp | |
| chβactin-R | CCTGAACCTCTCATTGCCA | ||
| chIL1-F | TGGGCATCAAGGGCTACA | 224 bp | |
| chIL1-R | TCGGGTTGGTTGGTGATG | ||
| chIL8-F | TTGGAAGCCACTTCAGTCAGAC | 120 bp | |
| chIL8-R | GGAGCAGGAGGAATTACCAGTT |